Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

[c0Mpr3$$]4aeUs34AAABCWmgzMUFZJlNZ8xjU6QAAKFeAQABxABhEVAAvLd4gIABIapk9JoG1NHqDan6hGkaQwTIYJjeTvVPgW71HDRSAD8xxbo/qqlDaEltSdCR6EzU5pppcqmjvxkwNGRAhsXckU4UJDzGNTpA=
  • USA - English


News provided by

iReachCompany

Nov 17, 2017, 11:11 ET

Share this article

Share toX

Share this article

Share toX


EUREKA, Calif., Nov. 17, 2017 /PRNewswire-iReach/ -- Papa & Barkley, a best-in-class manufacturer of effective cannabis-derived pain and wellness products, today announced the release of its 1:1 THCa:CBD tincture, created to give users the same healing properties as products made with THC, but with little or no psychoactivity. Papa & Barkley's innovative formulation not only includes THCa but is balanced with equal ratios of CBD to make a powerful wellness tincture that leverages the best of both cannabinoids. THCa helps with acute aches and pains, while CBD provides strong relief for inflammation and overall well-being, making the 1:1 THCa:CBD tincture unlike anything currently on the market.

"The new THCa:CBD tincture reflects our core mission - to improve the quality of people's lives by unlocking the power of the Plant," said Papa & Barkley CEO and Co-Founder, Adam Grossman. "THCa is the lesser-known cannabinoid found in raw cannabis; it has not been widely available in products because it is challenging to produce. We know that some consumers are nervous about psychoactivity. Our new tincture responds to these consumers' needs and keeps the entourage effect of CBD and THC, but with little or no psychoactivity."

Quote Text

Post this

Papa & Barkley creates highly effective, whole-plant products with absolutely no chemicals or solvents. The new THCa:CBD tincture is one of many items in the Company's popular "Releaf" line of wellness products. Tinctures were the most common way for patients to consume cannabis in the 1930's.  At this time, tinctures were available over the counter at drugstores. Cannabis tinctures remain popular today because they allow for precise and flexible dosing. Tinctures can be taken orally, sublingually, and even topically, making it one of the most versatile cannabis delivery methods. The Company's other tinctures are available in a 3:1 THC:CBD and 1:30 THC:CBD ratios.   

Many of Papa & Barkley's products are non-psychoactive, including its award-winning pain Releaf Balm™. The Company offers a wide range of products and delivery methods to broaden cannabis accessibility for consumers. In its continuing efforts to introduce consumers to the benefits and multiple uses of the Plant, Papa & Barkley has made its educational handbook, PlantMade, available to help shed light on these cannabinoids and tinctures. See here: https://papaandbarkley.com/plantmade/

About the THCa:CBD Tincture

Papa & Barkley's power-packed THCa:CBD tincture is available in 15 and 30ml bottles and contains over 900mg of total cannabinoids in the 30ml bottle. It is 100% solvent-free, whole plant infused, and results in limited to no psychoactivity. While CBD provides strong relief for inflammation and overall well-being, THCa helps with acute aches and pains. Recent studies suggest THCa, which only converts into THC when heated, has the same healing properties as THC, with the added benefit of mental clarity. Papa & Barkley believes its THCa tincture, will provide and effective form of pain relief for elderly patients, weekend warriors, and others who suffer from chronic or triggered pain. Papa & Barkley tinctures can be applied sublingually (under the tongue), put into any food/beverage or even applied topically. One dose has approximately 3.7 mg THCa / 1.0 mg THC / 3.7mg CBD. Onset usually begins within 15 minutes to two hours. It can be purchased at Medmen stores in Southern California, with more stores coming soon.

 About the PlantMade Handbook:

PlantMade is an educational tool meant to inform readers of all aspects of the cannabis plant and its benefits. It is a Cannabis 101 primer, and covers the history of cannabis as a healing plant, as well as various delivery methods, and the science behind cannabinoids (such as  THCa, CBD, and THC). The guide is an example of the Company's commitment to education and tackling some of the myths around cannabis. The guide is available online here: https://papaandbarkley.com/plantmade/

About Papa & Barkley:

Papa & Barkley™ is a premium wellness brand that creates highly effective, natural products that unlock the healing power of the cannabis plant. We improve people's lives through the creation of 100% natural pain and wellness products that leverage sun-grown cannabis flowers. All of our products are produced in our licensed, state-of-the-art manufacturing facility, located in Humboldt County, California.

Founded by caring for the ones we love, we are a team of scientists, caregivers and advocates who are committed to producing safe and reliable products from the whole plant. Our products are 100% solvent free and are offered in ratios of THC and CBD for a variety of conditions. To learn more about us please visit http://www.papaandbarkley.com/.

Connect with Papa & Barkley:

Website: http://www.papaandbarkley.com

Twitter:   https://twitter.com/papaandbarkley

Facebook: https://www.facebook.com/papaandbarkley/

Instagram: https://www.instagram.com/papaandbarkley/

Media Contact: Nicole Rodrigues, NRPR Group for Papa & Barkley, (650) 815-5069, [email protected]

News distributed by PR Newswire iReach: https://ireach.prnewswire.com

SOURCE NRPR Group for Papa & Barkley

iReach LastName, iReachCompany, 111-222-3333, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.